This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Molina Healthcare (MOH) Tops on Q4 Earnings, Issues '18 View
by Zacks Equity Research
Restructuring costs and impairment loss affect Molina Healthcare's (MOH) fourth-quarter results.
Ensign Group (ENSG) Beats on Q4 Earnings, Raises '18 View
by Zacks Equity Research
Ensign Group's (ENSG) top line rises in Q4 on solid segmental revenues.
Humana (HUM) Tops Q4 Earnings & Revenues, Issues '18 View
by Zacks Equity Research
Humana's (HUM) solid fourth-quarter results were driven by strong performance of Retail and Group & Specialty segments.
WellCare Health (WCG) Beats Q4 Earnings, Raises '18 View
by Zacks Equity Research
Solid organic and inorganic growth drives WellCare Health's (WCG) fourth-quarter results. However, higher expenses act as partial offset.
Centene (CNC) Beats Q4 Earnings & Revenues, Ups '18 View
by Zacks Equity Research
Centene's (CNC) fourth-quarter earnings were hurt by higher selling, general & administrative expenses.
Can Solid Retail Segment Drive Humana's (HUM) Q4 Earnings?
by Zacks Equity Research
Humana's (HUM) fourth-quarter results are likely to gain from solid premium growth, especially in the Retail segment.
Cigna Q4 Earnings Top on Higher Enrollment, 2018 View Issued
by Zacks Equity Research
Cigna (CI) Q4 earnings grow on higher revenues, which gained from higher premium and fees and increase in membership.
UnitedHealth Group (UNH): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
UnitedHealth Group (UNH) could be an interesting play for investors as it is seeing solid earnings estimate revision in addition to having a robust industry rank.
Top Ranked Momentum Stocks to Buy for February 1st
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 1st:
Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues '18 View
by Zacks Equity Research
Anthem (ANTM) reported strong fourth-quarter results on the back of solid performance across its segments.
HCA Healthcare's (HCA) Q4 Earnings, Revenues Beat Estimates (Revised)
by Zacks Equity Research
HCA Healthcare's (HCA) strong fourth-quarter results were driven by significant growth in admissions.
Aetna (AET) Q4 Earnings Top Estimates, Enrollment Declines
by Zacks Equity Research
Aetna (AET) results suffered from lower enrollment, investment spending and favorable development of prior-year health cost.
Can Pharmacy Services Drive CVS Health's (CVS) Q4 Earnings?
by Zacks Equity Research
CVS Health's (CVS) Q4 earnings are expected to gain from strength in the Pharmacy Services segment.
Zacks Industry Outlook Highlights: UnitedHealth, Humana, Cigna, Anthem and Centene
by Zacks Equity Research
Zacks Industry Outlook Highlights: UnitedHealth, Humana, Cigna, Anthem and Centene
Surging Earnings Estimates Signal Good News for UnitedHealth Group (UNH)
by Zacks Equity Research
UnitedHealth Group (UNH) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision, along with decent short-term momentum.
Zacks Industry Outlook Highlights: Aetna, Cigna, UnitedHealth and CVS Health
by Zacks Equity Research
Zacks Industry Outlook Highlights: Aetna, Cigna, UnitedHealth and CVS Health
Top Ranked Momentum Stocks to Buy for January 23rd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 23rd:
Top Analyst Reports for UnitedHealth, Amgen & United Technologies
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Amgen (AMGN) and United Technologies (UTX).
Stock Market News for Jan 17, 2018
by Zacks Equity Research
Benchmarks ended in the red on Tuesday after recent political tensions weighed on sentiment despite strong quarterly earnings results
UnitedHealth (UNH) Beats on Q4 Earnings, Revises 2018 View
by Zacks Equity Research
UnitedHealth (UNH) Q4 earnings reflect broad-based growth across both its segments.
UnitedHealth (UNH) Beats on Q4 Earnings Excluding Tax Impact
by Zacks Equity Research
UnitedHealth (UNH) Q4 earnings beat on higher revenues and increase in membership.
Are Stocks 'Irrationally Exuberant'?
by Sheraz Mian
It is a hard argument to make when earnings estimates are going up and interest rates remain accommodative.
Higher Optum Revenues to Drive UnitedHealth (UNH) Q4 Earnings
by Zacks Equity Research
Increased contribution across Optum's segments should support UnitedHealth's (UNH) earnings in Q4.
UnitedHealth's Q4 Earnings to Benefit From Higher Enrollment
by Zacks Equity Research
Higher membership across UnitedHealth's (UNH) government business, partially offset by a decline in enrollment in Commercial and Global operations will drive growth.
Robust Revenues to Drive UnitedHealth's (UNH) Q4 Earnings
by Zacks Equity Research
UnitedHealth's (UNH) Q4 earnings are likely to gain traction from improved enrollment, higher revenues from health service and benefit business plus a strong capital management.